Highlight HEALTH Web Directory » Drug Information » Cancer Therapy Subscribe to this category  


Sort by: PageRank | Hits | Alphabetical
Regular Links

PR: 3

Sprycel (dasatinib) is an oral multi-BCR/ABL and Src family tyrosine kinase inhibitor approved for use in patients with chronic myelogenous leukemia (CML) who are no longer benefitting from or cannot tolerate prior treatment including Gleevec (imatinib mesylate), and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL).
Date added: June 10, 2011   |   http://www.TreatmentForCML.com/   |   Link visits: 11